Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03552276 |
|---|---|
| Brief Title: | Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab. |
| First Submitted : | May 4, 2018 |
| First Submitted that Met QC Criteria : | June 8, 2018 |
| First Posted : | June 11, 2018 |
| Last Update Submitted that Met QC Criteria : | August 26, 2022 |
| Last Update Posted : | August 29, 2022 |